Evidence map›Paper›PMID 27266705›Full record

ArticleBMC genetics2016

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia.

Tasha E Fingerlin, Weiming Zhang, Ivana V Yang, Hannah C Ainsworth, Pamela H Russell, Rachel Z Blumhagen, Marvin I Schwarz, Kevin K Brown, Mark P Steele, James E Loyd and 43 more

Open access · diamondAbstract read
In one paragraph

Article in BMC genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Common single nucleotide polymorphisms associated with idiopathic pulmonary fibrosis: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Annals of the American Thoracic Society · 2025
    Article
  12. Review
  13. HLA-DR genotypes in patients with primary Sjögren's syndrome in Taiwan.The Kaohsiung journal of medical sciences · 2024
    Article
  14. Review
  15. Highlights on Future Treatments of IPF: Clues and Pitfalls.International journal of molecular sciences · 2024
    Review
  16. A Test to Comprehensively Capture the Known Genetic Component of Familial Pulmonary Fibrosis.American journal of respiratory cell and molecular biology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 15 institutions in 6 countries.

Tasha E FingerlinCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA. fingerlint@njhealth.org.
Weiming ZhangDepartment of Biostatistics and Informatics, University of Colorado Denver, Aurora, CO, USA.
Ivana V YangDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Hannah C AinsworthCenter for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Pamela H RussellDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Rachel Z BlumhagenCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
Marvin I SchwarzDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Kevin K BrownCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
Mark P SteeleDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
James E LoydDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Gregory P CosgroveCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
David A LynchCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
Steve GroshongCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
Harold R CollardDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Paul J WoltersDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.
Williamson Z BradfordInterMune, Brisbane, CA, USA.
Karl KossenInterMune, Brisbane, CA, USA.
Scott D SeiwertInterMune, Brisbane, CA, USA.
Roland M du BoisNational Heart and Lung Institute, Imperial College, London, UK.
Christine Kim GarciaDepartment of Medicine, University of Texas Southwestern, Dallas, TX, USA.
Megan S DevineDepartment of Medicine, University of Texas Southwestern, Dallas, TX, USA.
Gunnar GudmundssonLandspitali University Hospital and University of Iceland Faculty of Medicine, Reykjavik, Iceland.
Helgi J IsakssonLandspitali University Hospital and University of Iceland Faculty of Medicine, Reykjavik, Iceland.
Naftali KaminskiDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Yingze ZhangDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Kevin F GibsonDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Lisa H LancasterDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Toby M MaherNational Heart and Lung Institute, Imperial College, London, UK.
Philip L MolyneauxNational Heart and Lung Institute, Imperial College, London, UK.
Athol U WellsNational Heart and Lung Institute, Imperial College, London, UK.
Miriam F MoffattNational Heart and Lung Institute, Imperial College, London, UK.
Moises SelmanInstituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Annie PardoUniversidad Nacional Autonoma de Mexico, Mexico City, Mexico.
Dong Soon KimAsan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
James D CrapoCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
Barry J MakeCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
Elizabeth A ReganCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
Dinesha S WalekUniversity of Minnesota Genomics Center, University of Minnesota, Minneapolis, MN, USA.
Jerry J DanielUniversity of Minnesota Genomics Center, University of Minnesota, Minneapolis, MN, USA.
Yoichiro KamataniFondation Jean Dausset, Centre d'Étude du Polymorphisme Humain, Paris, France.
Diana ZelenikaCommissariat à l'Energie Atomique, Institut Génomique, Centre National de Génotypage, Evry, France.
Elissa MurphyDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Keith SmithDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
David McKeanDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Brent S PedersenDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Janet TalbertDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Julia PowersDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Cheryl R MarkinDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Kenneth B BeckmanUniversity of Minnesota Genomics Center, University of Minnesota, Minneapolis, MN, USA.
Mark LathropFondation Jean Dausset, Centre d'Étude du Polymorphisme Humain, Paris, France.
Brian FreedDepartment of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Carl D LangefeldCenter for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
David A SchwartzCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, USA. david.schwartz@ucdenver.edu.
University of Colorado Denver · USNational Institute for Health Research · GBNational Jewish Health · USVanderbilt University · USInterScience (United States) · USUniversity of Minnesota · USUniversity of Pittsburgh · USFondation Jean Dausset-CEPH · FRNational University Hospital of Iceland · ISThe University of Texas Southwestern Medical Center · USUniversity of California, San Francisco · USInstituto Nacional de Enfermedades Respiratorias · MXRoyal Brompton Hospital · GBUniversidad Nacional Autónoma de México · MXUniversity of Ulsan · KR

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Metabolomic signatures of empysema and COPD progression in the COPDGene cohortR01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2012 to 2016
$31.1M
Mechanisms of Familial Pulmonary FibrosisP01HL092870 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLACKWELL, TIMOTHY S. · 2010 to 2020
$21.6M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)R01HL097163 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FINGERLIN, TASHA E., SCHWARTZ, DAVID ALBERT · 2009 to 2018
$16.4M
Lung Genomics Research ConsortiumRC2HL101715 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GERACI, MARK W, KAMINSKI, NAFTALI · 2009 to 2010
$11.4M
Pulmonary Fibrosis and Telomerase DysfunctionR01HL093096 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GARCIA, CHRISTINE KIM · 2009 to 2024
$6.9M
Genomic Signatures for Idiopathic Interstitial PneumoniaR01HL095393 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SCHWARTZ, DAVID ALBERT · 2008 to 2011
$3.3M
Gene networks beyond organ boundaries; heart, lung and pulmonary vascular diseaseU01HL108642 · NHLBI · YALE UNIVERSITY · PI AHMAD, FERHAAN, BENOS, PANAGIOTIS V · 2011 to 2014
$2.2M
Functional Genetics in Idiopathic Pulmonary FibrosisR33HL120770 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SCHWARTZ, DAVID ALBERT · 2016 to 2018
$1.6M
Integrating linkage information in tests of association for rare variants in ILDR21HL113543 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FINGERLIN, TASHA E. · 2013 to 2014
$382k
NHLBI NIH HHS P01 HL092870NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01 HL089897NHLBI NIH HHS R01 HL093096NHLBI NIH HHS R01 HL095393NHLBI NIH HHS R01 HL097163NHLBI NIH HHS R21 HL113543NHLBI NIH HHS R33 HL120770NHLBI NIH HHS RC2 HL101715NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NHLBI NIH HHS U01 HL108642
6 · The paper itself

Abstract

backgroundFibrotic idiopathic interstitial pneumonias (fIIP) are a group of fatal lung diseases with largely unknown etiology and without definitive treatment other than lung transplant to prolong life. There is strong evidence for the importance of both rare and common genetic risk alleles in familial and sporadic disease. We have previously used genome-wide single nucleotide polymorphism data to identify 10 risk loci for fIIP. Here we extend that work to imputed genome-wide genotypes and conduct new RNA sequencing studies of lung tissue to identify and characterize new fIIP risk loci.

resultsWe performed genome-wide genotype imputation association analyses in 1616 non-Hispanic white (NHW) cases and 4683 NHW controls followed by validation and replication (878 cases, 2017 controls) genotyping and targeted gene expression in lung tissue. Following meta-analysis of the discovery and replication populations, we identified a novel fIIP locus in the HLA region of chromosome 6 (rs7887 P meta  = 3.7 × 10(-09)). Imputation of classic HLA alleles identified two in high linkage disequilibrium that are associated with fIIP (DRB1*15:01 P = 1.3 × 10(-7) and DQB1*06:02 P = 6.1 × 10(-8)). Targeted RNA-sequencing of the HLA locus identified 21 genes differentially expressed between fibrotic and control lung tissue (Q < 0.001), many of which are involved in immune and inflammatory response regulation. In addition, the putative risk alleles, DRB1*15:01 and DQB1*06:02, are associated with expression of the DQB1 gene among fIIP cases (Q < 1 × 10(-16)).

conclusionsWe have identified a genome-wide significant association between the HLA region and fIIP. Two HLA alleles are associated with fIIP and affect expression of HLA genes in lung tissue, indicating that the potential genetic risk due to HLA alleles may involve gene regulation in addition to altered protein structure. These studies reveal the importance of the HLA region for risk of fIIP and a basis for the potential etiologic role of auto-immunity in fIIP.

Indexed as

AdultAgedChromosomes, Human, Pair 6FemaleGene Expression ProfilingGene Expression RegulationGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHLA-DQ beta-ChainsHLA-DRB1 ChainsHumansIdiopathic Pulmonary FibrosisLinkage DisequilibriumMaleMiddle AgedHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DRB1 ChainsGene expressionHLA associationImputationPulmonary fibrosisRNA-Seq

Identifiers

PMID27266705
PMCPMC4895966
OpenAlexW2419637322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.